Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Clonal Persistence of Anti-PF4 Antibodies in VITT Represents an MGTS-like State

Adam Kanack, Guillaume Roberge, Emily Mauch, Noah Splinter, Geoffrey D. Wool, Gemlyn George, Mouhamed Yazan Abou-Ismail, Kristi J. Smock, David L. Green, Krishna Gundabolu, Jon Coker, Mindy Kohlhagen, David Murray, Anand Pabmanabhan

Blood (2024) 144 (Supplement 1): 1227.

https://doi.org/10.1182/blood-2024-208364

Published: 2024

Journal Articles

Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

Alicja Sadowska-Klasa, Sezen Ozkok, Hu Xie, Wendy Leisenring, Danniel Zamora, Sachiko Seo, Jordan Sheldon, Stephanie J. Lee, Margaret L Green, Michael Boeckh

Blood (2023) 142 (Supplement 1): 3583.

https://doi.org/10.1182/blood-2023-180305

Published: 2023

Journal Articles

Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases

Emily Abdelmessih, Stephanie Wo, David L. Green, Orly Leiva, Elaine Xiang, Tania Ahuja

Blood (2023) 142 (Supplement 1): 5122.

https://doi.org/10.1182/blood-2023-187523

Published: 2023

Journal Articles

Identifying Patterns of Neurocognitive Dysfunction through Direct Comparison of Patients with Leukemia, CNS Tumors, and Sickle Cell Disease

Claire Fraley, Jamie Neiman, Charlotte Feddersen, Claire James, Taylor Jones, Margit Mikkelsen, Kristen Miller, Paige Dillon, Amanda C. Winters, Alyssa M Schlenz, Rachelle Nuss, Adam L. Green, Bruce E. Compas

Blood (2022) 140 (Supplement 1): 10928–10929.

https://doi.org/10.1182/blood-2022-170361

Published: 2022

Journal Articles

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Blood (2022) 139 (10): 1541–1556.

https://doi.org/10.1182/blood.2021012734

Published: 2022

Includes: Supplemental data

Journal Articles

A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-Treated Cryopreserved Platelets for the Detection of Pathogenic HIT and VITT Antibodies

Adam Kanack, Curtis Jones, Bandana Singh, Gemlyn George, Mouhamed Yazan Abou-Ismail, David L. Green, Alison Grazioli, Rachel Leger, Nahla M. Heikal, Dong Chen, Rajiv K. Pruthi, Anand Padmanabhan

Blood (2021) 138 (Supplement 1): 2130.

https://doi.org/10.1182/blood-2021-152953

Published: 2021

Journal Articles

Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

Joshua A. Hill, Daniel Li, Kevin A. Hay, Margaret L. Green, Sindhu Cherian, Xueyan Chen, Stanley R. Riddell, David G. Maloney, Michael Boeckh, Cameron J. Turtle

Blood (2018) 131 (1): 121–130.

https://doi.org/10.1182/blood-2017-07-793760

Published: 2018

Includes: Supplemental data

Journal Articles

The Use of DNA Methylation Profiling to Assess the Significance of Different Types of Mutations in CEBPA -Mutated AML

Dima El-Sharkawi, MBBS, Claire L Green, PhD, Duncan Sproul, PhD, Sarah Jenkinson, MSc, Andrew Feber, PhD, David C Linch, FMedSci, Rosemary E Gale

Blood (2014) 124 (21): 2328.

https://doi.org/10.1182/blood.V124.21.2328.2328

Published: 2014

Journal Articles

Evaluation of Published Single-Nucleotide Polymorphisms (SNPs) Associated with Cytomegalovirus Infection and Disease after Hematopoietic Cell Transplantation in a Large Caucasian Cohort

Sachiko Seo, MD, Wenhong Fan, John A. Hansen, MD, Barry E. Storer, PhD, Steven A. Pergam, MDMPH, Margaret L. Green, MD, Sezen Ozkok, MD, Sonia Goyal, MD, Cynthia Fisher, MD, Sangeeta Hingorani, MD MPH, Edus H. Warren, MD PhD, Paul J. Martin, MD, Lue Ping Zhao, Michael Boeckh, MD

Blood (2014) 124 (21): 182.

https://doi.org/10.1182/blood.V124.21.182.182

Published: 2014

Journal Articles

Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT) in the Preemptive Therapy Era: Characteristics, Efficacy of PCR-Based Surveillance, and Impact on Mortality

Sezen Özkök, MD, Hu Xie, MS, Zach Stednick, Sachiko Seo, MD, Michael Boeckh, MD, Margaret L Green, MD

Blood (2014) 124 (21): 1135.

https://doi.org/10.1182/blood.V124.21.1135.1135

Published: 2014

Journal Articles

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

Marco Mielcarek, MD, Terrence Furlong, Barry E. Storer, PhD, Margaret L. Green, MD, Paul A. Carpenter, MD, George B McDonald, MD, Mary E. D. Flowers, MD, Rainer Storb, MD, Frederick R. Appelbaum, MD, Michael Boeckh, MD, Paul J. Martin, MD

Blood (2013) 122 (21): 703.

https://doi.org/10.1182/blood.V122.21.703.703

Published: 2013

Journal Articles

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Margaret L. Green, Wendy M. Leisenring, Hu Xie, Roland B. Walter, Marco Mielcarek, Brenda M. Sandmaier, Stanley R. Riddell, Michael Boeckh

Blood (2013) 122 (7): 1316–1324.

https://doi.org/10.1182/blood-2013-02-487074

Published: 2013

Includes: Supplemental data

Journal Articles

HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator

Tiejun Zhao, Yorifumi Satou, Kenji Sugata, Paola Miyazato, Patrick L. Green, Takeshi Imamura, Masao Matsuoka

Blood (2011) 118 (7): 1865–1876.

https://doi.org/10.1182/blood-2010-12-326199

Published: 2011

Includes: Supplemental data

Journal Articles

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation

Claire L. Green, Catherine M. Evans, Lu Zhao, Robert K. Hills, Alan K. Burnett, David C. Linch, Rosemary E. Gale

Blood (2011) 118 (2): 409–412.

https://doi.org/10.1182/blood-2010-12-322479

Published: 2011

Includes: Supplemental data

Journal Articles

Younger Adult Acute Myeloid Leukemia (AML) Patients with IDH2-R140 Mutations Have a Significantly Better Prognosis Than Those with Either IDH2-R172 or IDH1 Mutations

Claire L Green, Catherine M Evans, Robert Hills, MA, MSc, DPhil, Lu Zhao, Alan Burnett, David C Linch, MD, Rosemary Gale, PhD

Blood (2010) 116 (21): 100.

https://doi.org/10.1182/blood.V116.21.100.100

Published: 2010

Journal Articles

The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3 /ITD status

Claire L. Green, Catherine M. Evans, Robert K. Hills, Alan K. Burnett, David C. Linch, Rosemary E. Gale

Blood (2010) 116 (15): 2779–2782.

https://doi.org/10.1182/blood-2010-02-270926

Published: 2010

Includes: Supplemental data

Journal Articles

Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz , promotes T-lymphocyte proliferation

Joshua Arnold, Bevin Zimmerman, Min Li, Michael D. Lairmore, Patrick L. Green

Blood (2008) 112 (9): 3788–3797.

https://doi.org/10.1182/blood-2008-04-154286

Published: 2008

Journal Articles

Development of a New Fully Human Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies.

Gadi Gazit Bornstein, PhD, Christophe Queva, PhD, Mohammad Tabrizi, PhD, Anne VanAbbema, Carlos Chavez, Ping Wang, Naomi Laing, PhD, Sandhya Raja, PhD, Shenghua Wen, MD, Xianhui Rong, Larry L. Green, PhD, Xiaodong Yang, PhD, David Blakey, PhD

Blood (2007) 110 (11): 2349.

https://doi.org/10.1182/blood.V110.11.2349.2349

Published: 2007

Journal Articles

Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling

Jean-Claude Twizere, Jean-Yves Springael, Mathieu Boxus, Arsène Burny, Franck Dequiedt, Jean-François Dewulf, Julie Duchateau, Daniel Portetelle, Patrice Urbain, Carine Van Lint, Patrick L. Green, Renaud Mahieux, Marc Parmentier, Luc Willems, Richard Kettmann

Blood (2006) 109 (3): 1051–1060.

https://doi.org/10.1182/blood-2006-06-026781

Published: 2006

Includes: Supplemental data

Journal Articles

Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1

Joshua Arnold, Brenda Yamamoto, Min Li, Andrew J. Phipps, Ihab Younis, Michael D. Lairmore, Patrick L. Green

Blood (2006) 107 (10): 3976–3982.

https://doi.org/10.1182/blood-2005-11-4551

Published: 2006

NARROW

Clonal Persistence of Anti-PF4 Antibodies in VITT Represents an MGTS-like State

Late CMV Disease after Hematopoietic Cell Transplantation: Significance of Post-Transplant Cyclophosphamide, Steroid Treatment and CMV Viral Load

Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases

Identifying Patterns of Neurocognitive Dysfunction through Direct Comparison of Patients with Leukemia, CNS Tumors, and Sickle Cell Disease

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-Treated Cryopreserved Platelets for the Detection of Pathogenic HIT and VITT Antibodies

Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

The Use of DNA Methylation Profiling to Assess the Significance of Different Types of Mutations in CEBPA -Mutated AML

Evaluation of Published Single-Nucleotide Polymorphisms (SNPs) Associated with Cytomegalovirus Infection and Disease after Hematopoietic Cell Transplantation in a Large Caucasian Cohort

Late Cytomegalovirus Disease after Hematopoietic Cell Transplantation (HCT) in the Preemptive Therapy Era: Characteristics, Efficacy of PCR-Based Surveillance, and Impact on Mortality

Efficacy and Safety Of Lower-Dose Glucocorticoids For Initial Treatment Of Acute Graft-Versus-Host Disease: A Randomized Controlled Trial

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

HTLV-1 bZIP factor enhances TGF-β signaling through p300 coactivator

The prognostic significance of IDH2 mutations in AML depends on the location of the mutation

Younger Adult Acute Myeloid Leukemia (AML) Patients with IDH2-R140 Mutations Have a Significantly Better Prognosis Than Those with Either IDH2-R172 or IDH1 Mutations

The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3 /ITD status

Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz , promotes T-lymphocyte proliferation

Development of a New Fully Human Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies.

Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling

Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only